Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test cancer drugs and personalize cancer treatment.
Andrew Madoff died at Sloan Kettering Cancer Center, his lawyer told CNBC. Andrew was never charged criminally as part of his father's multi-billion dollar Ponzi scheme.
Eric Merola, director of two documentaries about the controversial cancer doctor Stanislaw Burzynski, now sets his sights on the internal cover-up of positive results for Laetrile at the Memorial Sloan Kettering Cancer Center in the 1970s.
Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.
Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK's digital reach.
They overcame the worst that life can throw at a kid - cancer and its debilitating surgeries, fatigue, vomiting and depression.
Memorial Sloan Kettering Cancer Center and Quest Diagnostics announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors. The goal is to use molecular laboratory...Show More Summary
Memorial Sloan Kettering Cancer Center launched the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, an ambitious initiative to improve cancer care and research through genomic analysis.
Three winners of the first-ever Breakthrough Prizes-- Charles L. Sawyers, MD, of Memorial Sloan Kettering Cancer Center; Cornelia I. Bargmann, PhD, of the Rockefeller University; and Lewis C. Cantley, PhD, of Weill Cornell Medical College...Show More Summary
We’ve been told that this has transpired in a matter of the last 24 hours, but yes, DigitasLBi has been appointed as agency partner for Memorial Sloan Kettering, the 130-year-old private cancer center based in NYC. We’ve been told that work for the center will be handled out of the New York and Boston DigitasLBi offices. Show More Summary
In the race for better treatments and possible cures, rare diseases are often left behind. In a collaboration of researchers at The Rockefeller University, Memorial Sloan Kettering Cancer Center and the New York Genome Center (NYGC), an unusual mutation has been found that is strongly linked to one such disease: a rare liver cancer that affects teens and young adults. read more
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment. The largest clinical study ever conducted to date of patients with advanced leukemia...Show More Summary
NEW YORK, February 19, 2014 — Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to...Show More Summary
Memorial Sloan Kettering Cancer Center and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.
IBM continues to expand the use of its Watson supercomputer from winning Jeopardy to handling incoming call-center questions to guiding cancer doctors at Memorial Sloan Kettering to better diagnoses. Today it announced a new pilot program for Watson at Houston’s renowned MD Anderson Cancer Center. The institution has been trying out Watson for a little [...]
On September 4, Kettering Medical Center (Kettering, Ohio) became the first clinic in North America to use Elekta's Versa HD™ system to treat a patient, a 71-year-old woman with medically inoperable lung cancer. The rapid speed of radiosurgery...Show More Summary
IBM’s Watson will team up with Memorial Sloan Kettering this fall and plans to launch in a handful of cancer care centers this year, but Dan Cerutti, IBM’s GM of Watson Commercialization, said today at GigaOM Structure that Watson could be used in other fields too. [...]
A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors...
A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors. read more
Gustin L. Reichbach: This is not a law-and-order issue; it is a medical and a human rights issue. Being treated at Memorial Sloan Kettering Cancer Center, I am receiving the absolute gold standard of medical care. But doctors cannot be expected to do what the law prohibits, even when they know it is in the best interests of their patients. Show More Summary